Our Take
A VC firm bought a hospital to move faster on health tech adoption, and the first visible output is AI phone calls—a tactic that works or fails entirely on voice quality and patient compliance, neither of which is reported here.
Why it matters
General Catalyst's bet that health systems are too slow to innovate is now testable in real conditions at Summa. Investors and health systems watching this deal need to know whether the VC model actually closes the adoption gap or just adds another layer of cost.
Do this week
Health system leaders: request a live demo of those AI phone calls from HATCo before signing any pilot agreement, and ask for patient uptake rates and satisfaction scores—vendors will have them.
General Catalyst's hospital plays with AI phone surgery prep
Eight months after acquiring Summa Health, the Ohio safety-net hospital system controlled by General Catalyst has begun deploying AI phone calls to help patients prepare for surgery and navigate care after discharge. This is part of a broader strategy by Health Assurance Transformation Company (HATCo), the holding company structure General Catalyst created to manage the October acquisition.
Summa serves as a testing ground for health technology tools built by companies in General Catalyst's portfolio. The VC firm intends to distribute these tools across more than two dozen partner health systems in HATCo's network. General Catalyst acquired Summa in response to what it saw as a systematic problem: health systems adopt new technology far too slowly.
In recent interviews, HATCo executives have begun describing how this transformation plan is unfolding. The AI phone system represents the first publicly visible initiative since the acquisition closed.
The bet: VC ownership moves faster than traditional adoption
The General Catalyst acquisition was rare. Venture capital firms almost never buy operating hospitals. The rationale reveals a real friction point in health tech: systems are bureaucratic, risk-averse, and slow to pilot new tools. By owning a health system outright, General Catalyst removes sales cycles and procurement delays.
But ownership solves a different problem than it solves for software. A hospital cannot be pivoted. Patient safety, regulatory compliance, and clinical staffing create hard constraints that no amount of venture capital can accelerate past. The AI phone calls may work or may fail based on whether patients actually use them, whether they improve clinical outcomes, and whether regulators approve the use case.
None of those outcomes are reported yet. The announcement is process-level: the tech is running, HATCo is talking about it, and the network is watching. Whether it works remains unanswered.
What health leaders should ask
Request concrete metrics from HATCo before treating Summa as a model: What percentage of eligible patients are receiving these calls? What is the completion rate? Do patients report the calls as helpful or intrusive? Are there safety flags from clinical teams? Have any calls led to adverse events?
The VC model works well for software adoption because you can deploy, measure, iterate, and scale. Hospitals cannot iterate as freely. A pilot that works at Summa may not transfer to a different system with different patient populations, different EHR systems, and different compliance requirements. Ask how HATCo plans to handle that gap before committing to their network.